Re: UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients: Is it time for everyone treated with irinotecan to be tested for UGT1A1 gene polymorphism?
作者信息
Kong Lingti, Rong Li, Wang Muhua
机构信息
Department of Pharmacy, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China; School of Pharmacy, Bengbu Medical College, Bengbu, China.
Department of Pharmacy, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China; School of Pharmacy, Bengbu Medical College, Bengbu, China.
出版信息
Eur J Cancer. 2022 Jul;170:194-195. doi: 10.1016/j.ejca.2022.03.044. Epub 2022 May 31.
PMID:35660253
Abstract
摘要
Zotero 插件